MT is a drug of choice for adrenocortical carcinoma . According to Ra calculation, the extent of compatibility between MT and triblocks was supposed to be in following order i.e. pBuOzi > pPrOzi ≈ pPentOx > pBuOx (Figure ). The measured aqueous MT solubility was found to be 0.0004 g/L (Table ). The formulation results revealed A-pPentOx-A to be the best solubilizer, yielding an aqueous MT solubility of around 7.2 g/L at 10 g/L MT feed (LC ≈ 42 wt.% and LE ≈ 72%) (Figure ). The second and third best solubilizer was found to A-pBuOx-A and A-pBuOzi-A with MT solubility of around 5.7 and 4.3 g/L (at 10 g/L MT feed) (LC ≈ 36 and 30 wt.%). The A-pPrOzi-A displayed relatively low solubility for MT i.e. 1.4 g/L (at 6 g/L feed) . Apparently, there is no correlation between compatibility estimation and formulation results. So far, the correlation between HSP based predicted compatibility and experimental formulation results for four polymers vs one drug were presented. To analyse the compatibility of 21 drugs for single polymer, the obtained results were replotted to present this trend to the readers (Figure ). On the left Y-axis Ra values are plotted with the decreasing order of compatibility between each polymer and drugs, while on the right Y-axis the actual solubility of drugs (as a formulation) is plotted. No correlation was observed between Ra based compatibility trend and the formulation results of 21 drugs with individual polymer.